REQUEST A DEMO
Total
USD $0.00
Search more companies

Kato Labs Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Kato Labs Sp. z o.o. Profile Updated: February 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Kato Labs Sp. z o.o. is based in Poland. The head office is in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. Kato Labs Sp. z o.o. was incorporated on March 18, 2002. Above 250 (2015) employees currently work for Kato Labs Sp. z o.o.. There was a net sales revenue drop of 7.72% reported in Kato Labs Sp. z o.o.’s latest financial highlights for 2022. Over the same period, its total assets grew by 14.75%. The net profit margin of Kato Labs Sp. z o.o. decreased by 6% in 2022.

Headquarters
Ul. Marszalkowska 138/82
Warsaw; Mazowieckie; Postal Code: 00-004

Contact Details: Purchase the Kato Labs Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Kato Labs Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Kato Labs Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Kato Labs Sp. z o.o. report to view the information.
Incorporation Date:
March 18, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99%
Company Performance
Financial values in the chart are available after Kato Labs Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-7.72%
Total operating revenue
-7.55%
Operating profit (EBIT)
-31.92%
EBITDA
-30.86%
Net Profit (Loss) for the Period
-22.51%
Total assets
14.75%
Total equity
14.68%
Operating Profit Margin (ROS)
-12.14%
Net Profit Margin
-6%
Return on Equity (ROE)
-6.15%
Quick Ratio
-0.06%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?